Cargando…
SAT678 Metabolic Disorders In Thalidomide Embryopathy
Disclosure: A. Tanabe: None. Thalidomide embryopathy (TE) is a disease that develops in neonates born from women who have taken thalidomide during early pregnancy. Most cases of TE are characterized by developmental abnormalities of the limbs and/or auditory organs. In Japan, thalidomide was markete...
Autor principal: | Tanabe, Akiyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553940/ http://dx.doi.org/10.1210/jendso/bvad114.126 |
Ejemplares similares
-
SAT672 Dulaglutide Might Reduce Visceral Fat In Patients With Metabolic Syndrome
por: Kim, Yu Na
Publicado: (2023) -
SAT-LB021 A Comparison of Criteria for Metabolic Syndrome in Nicaraguan Children
por: narvaez, federico
Publicado: (2019) -
SAT-098 Altered Metabolism in Obese Adolescents as a Factor for Gait Modification
por: Mirkovskaya, Liza
Publicado: (2019) -
SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
por: Sapre, Manali, et al.
Publicado: (2019) -
SAT650 Catecholamine-independent Neural Pathways Drive The Rapid Catabolism Of Metabolically Inert Fat
por: Zhang, Xiao, et al.
Publicado: (2023)